Primary hepatic lymphoma (PHL) is rare, accounting for less than 1% of all extranodal lymphomas. In this article, we retrospectively reviewed the imaging features of 12 pathologically proven cases of primary hepatic lymphoma.
Introduction
Non-Hodgkin lymphoma is frequently seen in the liver as part of the spectrum of widespread disease. Primary hepatic lymphoma (PHL) is, however, rare, representing less than 1% of all extranodal lymphomas.
1,2 Primary hepatic lymphoma presents with abdominal pain, fatigue, weight loss and a mass with or without jaundice. There is a male to female preponderance, 2 and presentation is largely in middle age. The pathologic diagnosis is usually diffuse large cell lymphoma or large B-cell lymphoma, 3, 4 or immunoblastic lymphoma in immunosuppressed patients, in whom the incidence is increased. 5 
Materials and methods
We retrospectively reviewed the imaging findings of patients with a histological diagnosis of PHL between 1996 and 2001. The study population consisted of 12 patients (nine men and three women), with a mean age of 63 years. Presenting symptoms or signs included right upper quadrant pain (five), laboratory abnormalities (five), constitutional symptoms (two) and gastrointestinal symptoms (two). One patient was HIV positive.
Eight patients had CT examinations and 10 patients had ultrasound. Imaging characteristics and differential diagnostic considerations of PHL are presented.
Results
During the 5-year period, 12 patients who satisfied the criteria for PHL, as described by Lei et al., 3 underwent either ultrasound or CT examinations. Three of the 12 patients presented with a single focal lesion (Fig. 1) . Eight of 12 patients presented with multiple well-defined lesions (Fig. 2) . One patient presented with a diffuse hepatic involvement (Fig. 3) . All eight patients who underwent CT evaluation demonstrated hypoattenuating solid lesions. Most of these were well-defined lesions (Fig. 4) . The lesions of three patients demonstrated rim enhancement following intravenous iodinated contrast administration (Fig. 5) . Three patients demonstrated target lesions on CT, with a hypoattenuating halo and central necrosis (Fig. 6 ).
All 10 patients who underwent ultrasound evaluation demonstrated solid appearing lesions, which were hypoechoic when compared with the adjacent liver (Fig. 7) . In five patients, some or all of the lesions demonstrated a 'target' appearance on ultrasound imaging (Fig. 8) . Fluorine-18-fluoro-2-deoxyglucose positron emission tomography (PET) was performed in one patient and demonstrated markedly increased uptake of the lymphomatous deposits (Fig. 9 ).
Discussion
Primary hepatic lymphoma represents a rare manifestation of the lymphoma spectrum. 6, 7 Presentation is Alpha-fetoprotein and carcinoembryonic antigen are often normal. 4, 9 Hypercalcaemia may also be present. 9 Immunosuppression increases the risk of nonHodgkin's lymphoma. There is an association with infections with hepatitis C and hepatitis B viruses. [10] [11] [12] The tumours are generally non-Hodgkin's in type. Diffuse large cell lymphoma is the most commonly encountered histological subtype. 13 Almost invariably, the tumour is composed of lymphocytes reacting with B-cell markers. Most cases are intermediate or high grade according to the classification of the working formulation for clinical usage. AIDS-related non-Hodgkin's lymphomas are considered highly aggressive and can include small non-cleaved, large immunoblastic and undifferentiated cell types. 5, 14 Our results confirm previous reports that PHL can present as a solitary mass or as multiple discrete masses. 15, 16 Three of our eight patients demonstrated a single hepatic mass, and eight demonstrated multiple masses. Rarely, the disease presents as diffuse involvement of the liver. 17 From our series of 12 patients, there was one case of diffuse disease. Our findings are concordant with previous papers describing the ultrasound appearances as of well-defined hypoechoic masses 15, 17 Our findings are also consistent with previous descriptions of hepatic lymphoma as of low attenuation on CT. 15, 17, 18 Rim enhancement has also been previously described. 15 There was no calcification in our series. Calcification has been previously described. 15, 18 However, intravenous contrast was used in all of our cases, possibly resulting in obscuration of small foci of calcification. There are no previous reports, to our knowledge, describing the target appearances we identified in three of our eight patients at CT and in five of our 10 patients at ultrasound. The criteria for establishing the diagnosis of PHL include both clinical and histopathological factors. In addition to histological evidence of hepatic lymphoma, Lei et al. deposits should demonstrate increased uptake, and the level of uptake may correlate with disease activity and tumour proliferation. 19 This is concordant with the finding of increased uptake when PET was studied in a single case of our series.
The imaging appearance of hepatic lymphoma is nonspecific and mainly includes hypovascular metastatic deposits. Colon, lung, prostate, gastric and transitional cell carcinomas are the most common primary tumours with hypovascular metastases to the liver. 20 Infectious (such as fungal and microbacterial) and inflammatory (such as sarcoidosis) pathologies can sometimes result in similar imaging appearances with multiple focal hepatic lesions, but clinical and laboratory values can often help in their differentiation.
There is little consistency in the literature regarding treatment of PHL. 21 The prognosis is generally perceived as dismal, with early disease recurrence at extra-hepatic locations and an overall short survival. 3 Reported median survival is as low as 6 months for patients treated with chemotherapy alone. Surgery and combination chemotherapy, either alone or with radiation, have all been described as viable management options. While there is little consistency in recommendations for management, recent studies indicate improved remission rates with combination chemotherapy. 4 High risk factors at the time of diagnosis include patient age, bulky disease and comorbidities, such as active hepatitis or cirrhosis. Given these factors, early detection is vital for patient management.
Conclusion
Primary hepatic lymphoma is a rare form of extranodal non-Hodgkin's disease that commonly presents with non-specific haepatobiliary signs and symptoms. There is a wide spectrum of imaging findings on CT and ultrasound. Like many other hepatic malignancies, PHL generally presents as hypoattenuating or hypoechoic lesions. Lesions may be single, multiple or diffuse. Rim enhancement is occasionally seen. A target appearance to the lesions on both ultrasound and CT is also seen. Primary hepatic lymphoma should be considered in the differential diagnosis of liver lesions when no primary malignancy is known.
